Global Nuclear Medicine/Radiopharmaceuticals Market was valued at USD 6.5 billion in 2019 which is expected to reach USD 12.25 billion by 2030 at a CAGR 9.88%.
Nuclear medicines/radiopharmaceuticals are radioactive compounds which are administered to patients and monitored via special imaging devices. These are used to diagnosis and therapeutic purposes. Nuclear medicines or radiopharmaceutical components are composed of organic molecules with radioisotopes. Radioisotopes emits gamma rays are used for diagnosis.
Increase in incidences of chronic diseases like cancer is the key driving factor which is expected to boost the global nuclear medicine/ radiopharmaceuticals market growth. For instance, in 2018, according to World Health Organization (WHO) around 9.6 million people were dead due to cancer across the world. Also, increase in prevalence of cardiovascular diseases will have the positive impact on global nuclear medicine/ radiopharmaceuticals market growth. Furthermore, increase in technological advancements is expected to propel the global nuclear medicine/ radiopharmaceuticals market growth.
However, short life of radiopharmaceuticals is the restraining factor for market which is expected to hamper the global nuclear/ radiopharmaceuticals market growth. Also, logistical difficulties, supply shortage and lack of qualified professionals will affect the global nuclear medicine/ radiopharmaceuticals market growth.
Global Nuclear Medicine/Radiopharmaceuticals Market is segmented into type such as Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals, Tc-99m, Tl-201, Ga-67, and Others), PET Radiopharmaceuticals (F-18, Rubidium-82, and Others), by procedure such as Brachytherapy Isotopes, Alpha Emitters, Beta Emitters, Therapeutic Procedures, PET Radiopharmaceuticals, and SPECT Radiopharmaceuticals. Further, Global Nuclear Medicine/Radiopharmaceuticals Market is segmented into application such as Cardiology, Oncology, Neurology, Thyroid, and Others.
Also, Global Nuclear Medicine/Radiopharmaceuticals Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in this report such as Iba Molecular, Advanced Accelerator Applications S.A., Nordion, Inc, Eczacibasi-Monrol Nuclear Products, Bracco Imaging S.P.A, Bayer AG, Lantheus Medical Imaging, Inc., GE Healthcare, Mallinckrodt PLC, and Cardinal Health, Inc.
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Nuclear Medicine/ Radiopharmaceuticals Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Nuclear Medicine/ Radiopharmaceuticals Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Nuclear Medicine/ Radiopharmaceuticals Market Share Analysis, By Type
5.3 Global Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Type
5.3.1 Diagnostic Nuclear Medicine
5.3.1.1 SPECT Radiopharmaceuticals
5.3.1.2 Tc-99m
5.3.1.3 TI-201
5.3.1.4 Ga-67
5.3.1.5 Others
5.3.2PET Radiopharmaceuticals
5.3.2.1F-18
5.3.2.2Rubidium-82
5.3.2.3Others
6 Global Nuclear Medicine/ Radiopharmaceuticals Market, By Procedure
6.1 Y-o-Y Growth Comparison, By Procedure
6.2 Global Nuclear Medicine/ Radiopharmaceuticals Market Share Analysis, By Procedure
6.3 Global Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Procedure
6.3.1 Brachytherapy Procedure
6.3.2 Alpha Emitters
6.3.3Beta Emitters
6.3.4 Therapeutic Procedures
6.3.5PET Radiopharmaceuticals
6.3.6SPECT Radiopharmaceuticals
7 Global Nuclear Medicine/ Radiopharmaceuticals Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global Nuclear Medicine/ Radiopharmaceuticals Market Share Analysis, By Application
7.3 Global Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Application
7.3.1 Cardiology
7.3.2 Oncology
7.3.3Neurology
7.3.4Thyroid
7.3.5Others
8 Global Nuclear Medicine/ Radiopharmaceuticals Market, By Region
8.1 Global Nuclear Medicine/ Radiopharmaceuticals Market Share Analysis, By Region
8.2 Global Nuclear Medicine/ Radiopharmaceuticals Market Share Analysis, By Region
8.3 Global Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Region
9 North America Nuclear Medicine/ Radiopharmaceuticals Market Analysis and Forecast (2017 – 2030)
9.1 Introduction
9.2 North America Nuclear Medicine/ Radiopharmaceuticals Market Share Analysis, By Type
9.3 North America Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Procedure
9.4 North America Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Application
9.5 North America Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Nuclear Medicine/ Radiopharmaceuticals Market Analysis and Forecast (2017 – 2030)
10.1 Introduction
10.2 Europe Nuclear Medicine/ Radiopharmaceuticals Market Share Analysis, By Type
10.3 Europe Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Procedure
10.4 Europe Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Application
10.5 Europe Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4. Rest of Europe
11 Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Analysis and Forecast (2017 – 2030)
11.1 Introduction
11.2 Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Share Analysis, By Type
11.3 Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Procedure
11.4 Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Application
11.5 Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Nuclear Medicine/ Radiopharmaceuticals Market Analysis and Forecast (2017 – 2030)
12.1 Introduction
12.2 Latin America Nuclear Medicine/ Radiopharmaceuticals Market Share Analysis, By Type
12.3 Latin America Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Procedure
12.4 Latin America Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Application
12.5 Latin America Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, Country
13 Middle East Nuclear Medicine/ Radiopharmaceuticals Market Analysis and Forecast (2017 – 2030)
13.1 Introduction
13.2 Middle East Nuclear Medicine/ Radiopharmaceuticals Market Share Analysis, By Type
13.3 Middle East Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Procedure
13.4 Middle East Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Application
13.5 Middle East Nuclear Medicine/ Radiopharmaceuticals Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Iba Molecular
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Accelerator Applications S.A
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Nordion, Inc
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Eczacibasi-Monrol Nuclear Products
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Bracco Imaging S.P.A,
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Bayer AG
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Lantheus Medical Imaging, Inc
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 GE Healthcare
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.8 GE Healthcare
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Mallinckrodt PLC
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.9 Cardinal Health, Inc
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
